Atlas Trials

Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

Clinical trial NCT03573518 · COMPLETED

Trial details

NCT number
NCT03573518
Sponsor
Botanix Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2018-06-26
Primary completion
2019-08-16
Enrollment
368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.